Household endotoxin levels and the risk of non-Hodgkin lymphoma

被引:0
|
作者
Jun Wang
Wendy Cozen
Peter S. Thorne
Kiros Berhane
James R. Cerhan
Patricia Hartge
Mary H. Ward
Anneclaire J. De Roos
Richard K. Severson
Lindsay M. Morton
Leslie Bernstein
Martha S. Linet
Joanne S. Colt
机构
[1] University of Southern California,Department of Preventive Medicine, USC Keck School of Medicine
[2] University of Southern California,Department of Pathology, USC Keck School of Medicine
[3] University of Southern California,Norris Comprehensive Cancer Center, USC Keck School of Medicine
[4] University of Iowa,Department of Occupational and Environmental Health
[5] Mayo Clinic,Division of Epidemiology, College of Medicine
[6] National Institutes of Health,Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute
[7] University of Washington,Division of Public Health Sciences, Department of Epidemiology, Fred Hutchinson Cancer Research Center and, School of Public Health
[8] Wayne State University,Department of Family Medicine and Public Health Sciences, School of Medicine
[9] Beckman Research Institute,Division of Cancer Etiology, Department of Population Sciences
来源
Cancer Causes & Control | 2013年 / 24卷
关键词
Endotoxin; Non-Hodgkin lymphoma; Epidemiology; Farming; Risk; Case–control;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:357 / 364
页数:7
相关论文
共 50 条
  • [31] Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma
    Frey, Connor
    Etminan, Mahyar
    LEUKEMIA & LYMPHOMA, 2025,
  • [32] Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors
    Xavier, Ana C.
    Armeson, Kent E.
    Hill, Elizabeth G.
    Costa, Luciano J.
    CANCER, 2013, 119 (18) : 3385 - 3392
  • [33] The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
    Dogan, Ahmet
    HAEMATOLOGICA, 2023, 108 (05) : 1220 - 1221
  • [34] Non-Hodgkin lymphoma
    Armitage, James O.
    Gascoyne, Randy D.
    Lunning, Matthew A.
    Cavalli, Franco
    LANCET, 2017, 390 (10091): : 298 - 310
  • [35] Non-Hodgkin lymphoma
    Shankland, Kate R.
    Armitage, James O.
    Hancock, Barry W.
    LANCET, 2012, 380 (9844): : 848 - 857
  • [36] Non-Hodgkin lymphoma
    Evans, LS
    Hancock, BW
    LANCET, 2003, 362 (9378): : 139 - 146
  • [37] Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma
    Biggar, Robert J.
    Christiansen, Michael
    Rostgaard, Klaus
    Smedby, Karin Ekstroem
    Adami, Hans-Olov
    Glimelius, Bengt
    Hjalgrim, Henrik
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (11) : 2616 - 2620
  • [38] Sun Exposure, Vitamin D, and Risk of Hodgkin and Non-Hodgkin Lymphoma
    Negri, Eva
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (07): : 878 - 882
  • [39] RISK OF SECOND MULTIPLE MYELOMA AFTER NON-HODGKIN AND HODGKIN LYMPHOMA
    Pugliese, N.
    Seneca, E.
    Catalano, L.
    Picardi, M.
    Cimmino, C.
    Cerchione, C.
    Di Perna, M.
    Pane, F.
    De Renzo, A.
    HAEMATOLOGICA, 2014, 99 : 692 - 692
  • [40] Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma
    Shepherd, Leah
    Ryom, Lene
    Law, Matthew
    Hatleberg, Camilla Ingrid
    de Wit, Stephane
    Monforte, Antonella d'Arminio
    Battegay, Manuel
    Phillips, Andrew
    Bonnet, Fabrice
    Reiss, Peter
    Pradier, Christian
    Grulich, Andrew
    Sabin, Caroline
    Lundgren, Jens
    Mocroft, Amanda
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (06): : 598 - 607